IL17A and breast cancer: The role of IL-17A in cancer is controversial: while IL-17 activates antineoplastic cytotoxic T cells in melanoma and ovarian cancer, it also induces an immunosuppressive microenvironment in mammary tumors and breast cancer tissues.